Antoine Papiernik | BiotechTV

top of page

Jefferies London: Sofinnova Partners announced a new $750M fund XI today that will invest in early stage companies in biotech

Chairman and Managing Partner Antoine Papiernik tells us about the fund and how he expects to deploy it. Plus, the current state of European biotech. Coverage brought to you by

Nov 17

With decades of experience, Sofinnova Partners' Chairman and Managing Partner Antoine Papiernik shares his thoughts on investing in life sciences and Europe

He describes Sofinnova Partners and its numerous investment strategies, the hidden gems of research expertise that can be found...

Bright Minds

Sep 4, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Jefferies London: Sofinnova Partners announced a new $750M fund XI today that will invest in early stage companies in biotech

With decades of experience, Sofinnova Partners' Chairman and Managing Partner Antoine Papiernik shares his thoughts on investing in life sciences and Europe

Follow BiotechTV

Sponsors

Sponsor Spotlight